一种基于时序代谢组学筛选中药复方中活性成分的方法

By combining temporal metabolomics and network pharmacology, the active ingredients in Xiandi Qianggu tablets were screened out, and a dynamic correlation network was constructed. This solved the problem of the lack of temporal action mechanism of active ingredients in traditional Chinese medicine compound preparations, and achieved effective treatment of osteoporosis.

CN116386759BActive Publication Date: 2026-07-17CHANGCHUN UNIV OF CHINESE MEDICINE

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
CHANGCHUN UNIV OF CHINESE MEDICINE
Filing Date
2023-04-06
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

In the existing technology, there is insufficient research on the temporal mechanism of action of active ingredients in traditional Chinese medicine compound formulas, making it difficult to screen effective compound groups through precise metabolomics analysis. Furthermore, the metabolite database is incomplete, making it impossible to systematically analyze the dynamic changes of traditional Chinese medicine compound formulas in the disease evolution process.

Method used

Using a time-series metabolomics-based approach, we separated and extracted the decoction of traditional Chinese medicine compound, membrane-separated components, and water-extracted and alcohol-precipitated components. These were then used to intervene in cell or animal disease models. Combined with network pharmacology analysis, the results were integrated through protein-protein interaction technology to screen for potential active components and effector targets. Molecular docking technology was then used to verify effective compounds or groups of compounds.

Benefits of technology

A "targeted component-effect target-temporal metabolism" network was constructed to elucidate the multi-pathway and temporal regulatory mechanism of bone formation by the active ingredient group of Xiandi Qianggu tablets. Effective active ingredients were screened out, and their efficacy in osteoporosis drugs was verified, providing a new approach for screening active ingredients of traditional Chinese medicine.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116386759B_ABST
    Figure CN116386759B_ABST
Patent Text Reader

Abstract

本发明提供一种基于时序代谢组学筛选中药复方中活性成分的方法,属于中药组分活性成分筛选技术领域。本发明建立相关疾病细胞和动物模型并给予中药复方提取的有效组分进行干预治疗;针对生物体代谢物进行时序代谢的观察和代谢组学技术的分析获得药物治疗后差异代谢物的信息;应用网络药理学、多元统计分析方法、分子对接技术寻找并鉴定差异化学成分,进而获得中药复方中具有活性作用的化合物或化合群,对本发明筛选出的活性成分进行活性验证,结果表明筛选出的化合物具有对应活性。本发明可以作为从中药体系中开发新药的方法,亦可为临床实践应用提供科学依据。
Need to check novelty before this filing date? Find Prior Art